A Study of RVT-1201 in Patients With Pulmonary Arterial Hypertension (ELEVATE 1)

NCT03924154 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Inability to enroll

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: RVT-1201
DRUG: Placebo

Sponsor

Altavant Sciences GmbH

Collaborators

[object Object]